CompletedNot Applicable

Secondary Prophylaxis of Gastric Variceal Bleed

China64 participantsStarted 2015-06

Plain-language summary

The purpose of this study is to study the efficacy of endoscopic cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration in the prevention of gastric variceal rebleeding and improvement in survival.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Cirrhosis
✓. Patients who had bled from GOV2 or IGV1（≥5 days and ≤ 28days）
✓. Presence of gastrorenal shunt

Exclusion criteria

✕. Previous treatment of gastric varices, including endoscopic therapy, NSBB, TIPS, or surgery
✕. Non-cirrhotic portal hypertension
✕. Contraindications to cyanoacrylate injection or BRTO
✕. Portal cavernoma
✕. Hepatorenal syndrome
✕. Proven malignancy including hepatocellular carcinoma
✕. End-stage renal disease under renal replacement therapy;
✕. Cardiorespiratory failure

What they're measuring

Rebleeding rate from gastric varices

Timeframe: 3 years

Trial details

NCT IDNCT02468206

SponsorWest China Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-02-28

View on ClinicalTrials.gov More Gastric Varices trials